Literature DB >> 26512174

Congenital Dermatofibrosarcoma Protuberans: A Case Report and Literature Review.

Hyun Ho Han1, Soo Yeon Lim1, Young Min Park2, Jong Won Rhie1.   

Abstract

Congenital dermatofibrosarcoma protuberans (DFSP) is an extremely rare skin tumor that is commonly misdiagnosed, or is often diagnosed long after the initial presentation. Although many cases of DFSP are diagnosed in adulthood, there are some differences between adult DFSP and congenital DFSP. We report a case of congenital DFSP that was initially misdiagnosed as a simple vascular lesion. The delay in diagnosis led to the considerable growth of the lesion, such that a huge scar was left after the surgical treatment. The major differences between adult and congenital DFSP are discussed through a literature review. Clinicians should be aware of the characteristics of congenital DFSP, to reduce misdiagnosis and the delay of diagnosis from the initial presentation.

Entities:  

Keywords:  Age of onset; Congenital; Dermatofibrosarcoma; Diagnosis

Year:  2015        PMID: 26512174      PMCID: PMC4622894          DOI: 10.5021/ad.2015.27.5.597

Source DB:  PubMed          Journal:  Ann Dermatol        ISSN: 1013-9087            Impact factor:   1.444


  14 in total

1.  Dermatofibrosarcoma protuberans. A study of 115 cases.

Authors:  H B TAYLOR; E B HELWIG
Journal:  Cancer       Date:  1962 Jul-Aug       Impact factor: 6.860

2.  Dermato-fibrosarcoma protuberans. A report of 39 cases.

Authors:  G T PACK; E J TABAH
Journal:  AMA Arch Surg       Date:  1951-03

3.  Dermatofibrosarcoma protuberans: an analysis of 86 cases--five with metastasis.

Authors:  C J McPeak; T Cruz; A D Nicastri
Journal:  Ann Surg       Date:  1967-11       Impact factor: 12.969

4.  Dermatofibrosarcoma protuberans. Study of fifty-six cases.

Authors:  B R Burkhardt; E H Soule; R K Winkelmann; J C Ivins
Journal:  Am J Surg       Date:  1966-05       Impact factor: 2.565

5.  Congenital dermatofibrosarcoma protuberans: variability in presentation.

Authors:  Jill M Weinstein; Beth A Drolet; Nancy B Esterly; Maureen Rogers; Bruce S Bauer; Annette M Wagner; Anthony J Mancini
Journal:  Arch Dermatol       Date:  2003-02

6.  Molecular targeting of platelet-derived growth factor B by imatinib mesylate in a patient with metastatic dermatofibrosarcoma protuberans.

Authors:  Brian P Rubin; Scott M Schuetze; Janet F Eary; Thomas H Norwood; Sohail Mirza; Ernest U Conrad; James D Bruckner
Journal:  J Clin Oncol       Date:  2002-09-01       Impact factor: 44.544

7.  Dermatofibrosarcoma protuberans. A clinico-pathological study of nineteen cases and review of world literature.

Authors:  K Bendix-Hansen; O Myhre-Jensen; S Kaae
Journal:  Scand J Plast Reconstr Surg       Date:  1983

8.  Dermatofibrosarcoma protuberans in childhood and adolescence: report of eight patients.

Authors:  Fatemeh Jafarian; Catherine McCuaig; Victor Kokta; Louise Laberge; Bourouia Ben Nejma
Journal:  Pediatr Dermatol       Date:  2008 May-Jun       Impact factor: 1.588

9.  Dermatofibrosarcoma protuberans in children.

Authors:  Chaitan Reddy; Peter Hayward; Phillip Thompson; Alex Kan
Journal:  J Plast Reconstr Aesthet Surg       Date:  2007-12-21       Impact factor: 2.740

10.  CD34 immunoreactivity distinguishes between scar tissue and residual tumor in re-excisional specimens of dermatofibrosarcoma protuberans.

Authors:  V G Prieto; J A Reed; C R Shea
Journal:  J Cutan Pathol       Date:  1994-08       Impact factor: 1.587

View more
  1 in total

1.  A case of congenital dermatofibrosarcoma protuberans in a 2-year-old child.

Authors:  Francesca Caroppo; Roberto Salmaso; Elena Fontana; Anna Belloni Fortina
Journal:  JAAD Case Rep       Date:  2020-05-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.